Skip to main content

Canada to Consider Gene Patent Eligibility: Looking Abroad for Insight

March 2, 2016

Melanie Szweras and Teresa MacLean write for Biotechnology Focus Magazine discussing how gene patent elgibility in Canada may soon be evaluated in light of a challenge brought by the Children's Hospital of Eastern Ontario (CHEO).

To read the article please click here or download the PDF below.

Content shared on Bereskin & Parr’s website is for information purposes only. It should not be taken as legal or professional advice. To obtain such advice, please contact a Bereskin & Parr LLP professional. We will be pleased to help you.

Author(s):

Melanie Szweras Melanie Szweras
B.Sc., Ph.D. (Genetics), LL.B.
Partner
416.957.1678  email Melanie Szweras